1949801-52-8
Chemical Structure
LXRβ agonist-2
- CAS No.: 1949801-52-8
- Formula:C32H31F6N3O7
- Molecular Weight:683.59
IUPAC Name: (S)-3-(2-(4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2-propylphenoxy)-2-hydroxyphenyl)-2-oxoethyl)-5-(5-isopropoxypyridin-2-yl)-5-methylimidazolidine-2,4-dione
InChIKey: PFNIPVRYLSNESB-LJAQVGFWSA-N
SMILES: OC(C(F)(F)F)(C(F)(F)F)C1=CC(CCC)=C(OC2=CC(O)=C(C(CN3C(N[C@@](C)(C4=NC=C(OC(C)C)C=C4)C3=O)=O)=O)C=C2)C=C1
Biological Activity: LXRβ agonist-2 is an orally active and selective LXRβ agonist. LXRβ agonist-2 increases high-density lipoprotein cholesterol levels without elevating plasma triglyceride levels. LXRβ agonist-2 decreases lipid accumulation area in the aortic arch. LXRβ agonist-2 can be used for the research of atherosclerosis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
LXRβ agonist-2 | LXRβ agonist-2 is an orally active and selective LXRβ agonist. LXRβ agonist-2 increases high-density lipoprotein cholesterol levels without elevating plasma triglyceride levels. LXRβ agonist-2 decreases lipid accumulation area in the aortic arch. LXRβ agonist-2 can be used for the research of atherosclerosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
